InvestorsHub Logo
Followers 28
Posts 2529
Boards Moderated 0
Alias Born 05/08/2015

Re: Scooter McCabe post# 185351

Wednesday, 09/22/2021 9:49:30 AM

Wednesday, September 22, 2021 9:49:30 AM

Post# of 233148
It's common knowledge the half life of leronlimab is about 10 days meaning that the effect of the drug would have been much less at day 28. Thanks for pointing that out and why this trial will have a much higher success rate. This will leave the other failed MABs like HGEN's in the dust.

The treatment with leronlimab was only for two doses (day 0 and day 7); from day 14 to 28, the survival rate declined from 82% to 30%...


My comments are just my opinions and should NOT be taken as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News